TOLVAPTAN

Generic: TOLVAPTAN

Ascend LaboratoriesManufacturer
ORALRoute
TOLVAPTANActive Substance
2026-04-21Original Approval

TOLVAPTAN is FDA application ANDA220147, sponsored by ALKEM LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
THIRST
892 reports
2
PRODUCT DOSE OMISSION ISSUE
749 reports
3
DEATH
585 reports
4
POLLAKIURIA
572 reports
5
RENAL IMPAIRMENT
522 reports
6
POLYURIA
411 reports
7
NO ADVERSE EVENT
407 reports
8
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
405 reports
9
FATIGUE
385 reports
10
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
368 reports